Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the <scp>EMPULSE</scp> trial

Adriaan A. Voors, Kevin Damman, John R. Teerlink, Christiane E. Angermann, Sean P. Collins, Mikhail Kosiborod, Jan Biegus, João Pedro Ferreira, Michael E. Nassif, Mitchell A. Psotka, Jasper Tromp, Martina Brueckmann, Jonathan P. Blatchford, Afshin Salsali, Piotr Ponikowski, Unknown

Open source

DOI: 10.1002/ejhf.2681
Published: 2022-09-27
Container: European Journal of Heart Failure
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ejhf.2681,
  title = {Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the
                    <scp>EMPULSE</scp>
                    trial},
  author = {Adriaan A. Voors and Kevin Damman and John R. Teerlink and Christiane E. Angermann and Sean P. Collins and Mikhail Kosiborod and Jan Biegus and João Pedro Ferreira and Michael E. Nassif and Mitchell A. Psotka and Jasper Tromp and Martina Brueckmann and Jonathan P. Blatchford and Afshin Salsali and Piotr Ponikowski and Unknown},
  year = {2022},
  journal = {European Journal of Heart Failure},
  doi = {10.1002/ejhf.2681},
  url = {https://doi.org/10.1002/ejhf.2681}
}

RIS

TY  - JOUR
TI  - Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the
                    <scp>EMPULSE</scp>
                    trial
AU  - Adriaan A. Voors
AU  - Kevin Damman
AU  - John R. Teerlink
AU  - Christiane E. Angermann
AU  - Sean P. Collins
AU  - Mikhail Kosiborod
AU  - Jan Biegus
AU  - João Pedro Ferreira
AU  - Michael E. Nassif
AU  - Mitchell A. Psotka
AU  - Jasper Tromp
AU  - Martina Brueckmann
AU  - Jonathan P. Blatchford
AU  - Afshin Salsali
AU  - Piotr Ponikowski
AU  - Unknown
PY  - 2022
JO  - European Journal of Heart Failure
DO  - 10.1002/ejhf.2681
UR  - https://doi.org/10.1002/ejhf.2681
ER  -

APA

Voors, A. A., Damman, K., Teerlink, J. R., Angermann, C. E., Collins, S. P., Kosiborod, M., Biegus, J., Ferreira, J. P., Nassif, M. E., Psotka, M. A., Tromp, J., Brueckmann, M., Blatchford, J. P., Salsali, A., Ponikowski, P., & Unknown (2022). Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the <scp>EMPULSE</scp> trial. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.2681

Source records

crossref · retrieved 2026-09-25T07:13:41.926Z